ARTeSYN Biosolutions

ARTeSYN Biosolutions was a private bioprocessing technology company focused on designing and manufacturing single-use systems, valves, flow paths, and related components for biopharmaceutical manufacturing. Its products were used primarily in downstream processing workflows including chromatography, filtration, media and buffer preparation, and continuous manufacturing rather than in therapeutic drug development. The company served biologics manufacturers with automation-focused, low hold-up-volume systems intended to improve yield, reduce product loss, and simplify single-use operations. ARTeSYN was acquired by Repligen in a transaction announced on October 27, 2020 and closed on December 3, 2020, after which the brand and product line were integrated into Repligen’s bioprocessing portfolio. The business is therefore healthcare-related as a supplier to biopharma manufacturing, but it is not a therapeutics developer.